Skip to content

Mark Benjamin, M.D.

NPI 1992760185ActiveIndividual· Specialist· Philadelphia, PA

Specialist (M.D.) in Philadelphia, Pennsylvania, licensed in PA, with an NPI issued in April 2006. Their prescriptions cost Medicare Part D more than their services did: $199,150 for 512 claims, against $57,139 paid for services in 2024. Astrazeneca Pharmaceuticals LP was the largest of 7 companies reporting payments in 2024, $1,138 in all, mostly food and beverage.

Overview

NPI1992760185
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedApr 19, 2006
Last updated in NPPESJul 8, 2007

Specialties and licenses

TaxonomyCodeLicenseState
Specialist Primary174400000XMD026817EPA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients162
Services billed1,467 across 14 procedure codes
Paid by Medicare$57,139

Part D prescriptions in 2024

Prescriptions (claims)512 · 623 30-day fills
Patients70
Total drug cost$199,150
Generic share32% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2024$1,138 · 53 payments from 7 companies

Top paying companies in 2024

What the 2024 payments were for

  • Food and Beverage$1,138 · 53 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Specialist providers in Philadelphia

All 184 Specialist providers in Philadelphia · All Specialist providers in Pennsylvania